Showing results (21-30 of 399) with videos related to
Sort By:
Pageof 40
British Journal of Haematology|February 24, 2005
Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapyPeter Bader, Charlotte Niemeyer, Andre Willasch, et al.Haematologica|April 10, 2010
Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantationSelim Kuçi, Eva Rettinger, Bernhard Voss, et al.Pediatric Diabetes|December 6, 2003
Ketoacidosis at onset of type 1 diabetes mellitus in children--frequency and clinical presentationAndreas Neu, Andre Willasch, Stefan Ehehalt, et al.Current Opinion in Hematology|September 22, 2015
Challenges and opportunities of allogeneic donor-derived CAR T cellsYinmeng Yang, Elad Jacoby, Terry J FryCurrent Hematologic Malignancy Reports|July 24, 2019
Multi-Specific CAR Targeting to Prevent Antigen EscapeZachary Walsh, Savannah Ross, Terry J FryFrontiers in Pediatrics|October 21, 2015
Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaHaneen Shalabi, Anne Angiolillo, Terry J FryClinical Immunology (Orlando, Fla.)|June 13, 2006
Autoimmunity during lymphopenia: a two-hit modelTom Krupica, Terry J Fry, Crystal L MackallFrontiers in Oncology|May 22, 2014
Murine models of acute leukemia: important tools in current pediatric leukemia researchElad Jacoby, Christopher D Chien, Terry J FryJournal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Cytokine signals in T-cell homeostasisMartin Guimond, Terry J Fry, Crystal L MackallPlos One|September 28, 2017
Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndromeYang Jo Chung, Terry J Fry, Peter D AplanPageof 40